Especially given its impact on cardiology, the WHI should be the “pride” of the US, not on the chopping block, says Martha ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

In aneurysms normally chosen for surveillance, the endovascular technique slowed growth by 70% in the small phase I trial.